The MLR Review Process: Why Promotional Materials Get Sent Back 10+ Times

Ask anyone who has pushed a promotional piece through MLR review for their war story, and you will get a number. One agency lead we spoke with said the version they finally uploaded to Veeva was v35. Not version three, or version five. Thirty-five.

A clean piece should clear the MLR review process in two or three rounds. Plenty take ten or more, and every extra round costs the same three things: days on the timeline (the average content approval cycle runs around 21 days, and the messy ones run much longer), reviewer hours, and a launch date that keeps sliding.

So why does the same process loop so many times? It is almost never one big failure. It is the same handful of small ones, compounding. Here are the real causes, and what actually shortens the cycle.

1. The submission was never review-ready

The strongest predictor of how many rounds a piece needs is the state it arrives in. When a draft lands without each claim linked and anchored to the exact line of its source, the reviewer cannot simply verify it. They have to reconstruct it, hunting through PDFs for the sentence that supports each claim.

The data backs this up. In a 2025 analysis of medical reviewers, the time to review a single promotional one-pager ranged from under an hour to more than five (N=192). The deciding factor was not length. It was quality: whether the claims had been pre-aligned, and whether the references actually supported them. The same one-page leave-behind is a ten-minute job or a lost weekend, depending entirely on who prepared it. We dig into that failure mode in why your MLR process is broken before it starts.

2. Every audience needs its own wording, and every wording is its own review

The claim you make to a physician is not the claim you make to a pharmacist, and neither is what you are allowed to show a patient who has already been prescribed the product. Each of those is a separate piece of copy, with its own substantiation, and each one goes through review on its own.

Multiply one core message across three or four audiences and channels and you have not created one review job. You have created three or four, each able to loop independently.

3. A single word can reset the whole cycle

This is the one that makes creative teams despair. A legal reviewer asks to soften a single adjective, "clear" becomes "clearer," and because that word sits inside a claim, the claim has to be re-substantiated and the piece loops back through review. These late, tiny changes are normal rather than exceptional, and they often land at the very end of the process, after everyone thought the piece was done.

Claim drift works the same way in reverse: the quiet addition of a "unique" or a "first-line" that nobody flagged turns a previously approved claim into a new one that has to be re-reviewed. And the specifics invite scrutiny. Study parameters, the exact patient number, the comparator arm, the endpoint wording, are precisely the details a careful reviewer stops on, and precisely the ones a copywriter is tempted to round off.

4. The reviewers do not always agree, even with each other

MLR is not one gate. It is three (medical, legal, and regulatory), plus the marketing or agency team that wrote the piece, and they do not share a single definition of "approved." Marketing writes the ambitious claim; medical and regulatory have to make it defensible. That tension is healthy, but it is also rounds.

The most expensive version is internal. The senior medical signatory sometimes overrules feedback their own team already gave, so a change made in round four to satisfy one reviewer gets reversed in round eight by another. When 52% of practitioners say accountability for MLR should sit with a cross-functional team rather than any one person, this is the flip side: shared accountability without shared judgment means more voices, and more rounds. (More on who actually owns the process in our complete guide to MLR review.)

5. Nobody remembers why the last version was rejected

Agencies and brand teams turn over. The person who learned, the hard way, that a particular phrasing would never clear review is gone next year, and the lesson left with them. Approved claims are not always formalized in the claims library, and external agencies frequently cannot see the full library anyway, so they rebuild from scratch, sometimes re-submitting wording that was already rejected once.

Without a durable record of what was rejected and why, the cycle does not just repeat inside one project. It repeats across every project that follows.

How to make the first round count

You cannot legislate away disagreement, and you would not want to; that friction is doing real compliance work. But most of the rounds above are not disagreement. They are avoidable rework, and three habits remove most of it:

Arrive review-ready. Every claim linked and anchored to the exact line of its source, so the first round is verification, not reconstruction. (Even formatting the reference cleanly helps; our free AMA citation generator turns a PubMed record into a clean citation in one paste.)
Keep a living claim library, with its rejections. Lock approved claims to their references so they are reused, and record what was rejected and why so it is not re-submitted.
Pre-align before you submit. Get medical and legal to weigh in on the wording before it is baked into a designed, laid-out piece, so the word-level changes happen on a draft, not on version 30.

This is the gap PharmaText.ai was built to close. Our Precision Traceability engine anchors every claim to its source as the content is drafted, so what reaches MLR is already linked, already anchored, and ready to be verified instead of reconstructed. It will not get you to version one. But it can get you out of version 35.

Sources: promotional-review time data from the Medical Affairs workload overview by Maaike Addicks, medicalaffairs.nl (2025); MLR accountability polling from a 2024 industry webinar by Impatient Health.